What is Efavirenz-lamivudine-tenofovir disoproxil (EFV/3TC/TDF)?

Category: Prescription Drugs

Most popular types: Symfi Symfi Lo

false

Efavirenz-lamivudine-tenofovir disoproxil is a combination single-tablet medication used for the treatment of HIV infection.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 1
Mild 0
None 3

Commonly reported side effects and conditions associated with Efavirenz-lamivudine-tenofovir disoproxil (EFV/3TC/TDF)

Side effect Patients Percentage
Insomnia 1
Adherence
Adherence Evaluations Percentage
Always 4
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 4

What people switch to and from

Patients started taking Efavirenz-lamivudine-tenofovir disoproxil (EFV/3TC/TDF) after stopping:

Treatment Patients Percentage
Efavirenz (EFV) (Sustiva) 3
Lamivudine (3TC) (Epivir) 2
Tenofovir disoproxil fumarate (Viread) 2
Lamivudine-Zidovudine (3TC/ZDV) (Combivir) 1
Last updated:

1 patient evaluation for Efavirenz-lamivudine-tenofovir disoproxil (EFV/3TC/TDF)

May 3, 2016 (Started May 11, 2015)

  • Effectiveness
    Major (for acquired immune deficiency syndrome (AIDS))
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 1 capsule(s) Daily

Feb 4, 2016 (Started May 11, 2015)

  • Effectiveness
    Can't tell (for acquired immune deficiency syndrome (AIDS))
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 1 capsule(s) Daily

Jun 5, 2015 (Started May 11, 2015)

  • Effectiveness
    Major (for acquired immune deficiency syndrome (AIDS))
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 1 capsule(s) Daily

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Efavirenz-lamivudine-tenofovir disoproxil (EFV/3TC/TDF)